Product development director at Shire Pharmaceuticals, leading development of drug product assets at various stages of the development cycle using an out sourced model. Specific responsibility in developing a QbD roadmap for Shire R&D and the practical application of risk managment tools during process and product design phases. Prior to this, worked at Pfizer, Wyeth, P&G and GSK across multiple functions from analytical to clinical claims support. Extensive experience in developing QbD tools for application in both drug product and analytical development. First degree in chemistry/chemical engineering from Northumbria University, PhD gained in organic chemistry from Univeristy of London.